EuroPCR 2019 | Intravascular Imaging Almost Indispensable for Planning an Angioplasty

Cost and time are the two main enemies of intravascular imaging, but lack of expertise may also play a role.

A new European Association of Percutaneous Cardiovascular Interventions (EAPCI) expert consensus statement released at EuroPCR 2019 argues that there is a need for more use of intracoronary imaging in settings of acute coronary syndromes and ambiguous coronary angiography findings, in order to guide interventions based on plaque characteristics.

Procedural time and costs are often cited as barriers to higher use of intravascular ultrasound (IVUS) or optical coherence tomography (OCT) imaging, but experts consider that the biggest barrier is likely the lack of operator expertise in interpreting imaging results.

This new document follows a “Part 1” presented and published at EuroPCR last year, clarifying that the use of intracoronary imaging enhances patient selection and procedural optimization. Part 2 was presented yesterday at EuroPCR, simultaneously published in the European Heart Journal, and endorsed by many scientific societies worldwide.


Read also: EuroPCR 2019 | REVELATION: Drug Coated Balloons in ST Elevation MI.


The latest European guidelines for myocardial revascularization upgraded the recommendations for OCT to class IIa for the optimization of stent placement, thus matching the recommendation for IVUS in this context. IVUS can also be considered for the assessment of lesion severity for left main coronary artery lesions (class IIa), and both IVUS and OCT should be considered for the detection of mechanical problems leading to restenosis (class IIa).

More evidence in support of intracoronary imaging emerged between EuroPCR editions. The ULTIMATE study, presented at TCT 2018, showed a 2.5% absolute reduction in the risk of target vessel failure among patients who underwent DES implantation guided by IVUS vs. angiography alone.

Intracoronary imaging is not merely a procedural tool during stent implantation, but also a means to better understand plaque morphology and its composition, and detect culprit lesions and markers of vulnerability.

Original Title:  Clinical use of intracoronary imaging. Part 2: acute coronary syndromes, ambiguous coronary angiography findings, and guiding interventional decision-making: an expert consensus document of the European Association of Percutaneous Cardiovascular Interventions.

Reference: Johnson T et al. Eur Heart J. 2019; Epub ahead of print.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Plaque Ruptures in Non-Culprit Arteries: Follow-Up With Intravascular Imaging

Plaque rupture remains one of the most important pathophysiological mechanisms in acute coronary syndromes. However, not all ruptures manifest clinically as ischemia, myocardial infarction,...

OCT-Detected High-Risk Plaques Predict Recurrent Events After Myocardial Infarction

After a myocardial infarction (MI), non-culprit lesions are often deferred when they are not flow-limiting (negative FFR). However, these lesions continue to represent an...

Ticagrelor vs Clopidogrel in ACS Patients Receiving DOAC After PCI: More Bleeding Without Ischemic Benefit?

In patients with acute coronary syndrome (ACS) who require direct oral anticoagulation (DOAC) and undergo percutaneous coronary intervention (PCI), current guidelines recommend a dual...

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

SPYRAL Program: 3-Year Outcomes in Patients Treated with Renal Denervation

Hypertension is the leading modifiable risk factor for cardiovascular disease and remains a major global health challenge, affecting more than one billion adults worldwide.  Despite...

Coronary Obstruction During TAVI: A New Volumetric Index to Consider

Coronary obstruction during TAVI is an uncommon but potentially catastrophic complication, particularly in valve-in-valve procedures, in anatomies with small sinuses of Valsalva, low coronary...

EARLY TAVR: Impact of Age on Outcomes of Early TAVR in Asymptomatic Patients

Asymptomatic severe aortic stenosis represents an increasingly common clinical challenge. Although current guidelines recommend intervention once symptoms develop or left ventricular dysfunction occurs, concerns...